The initial success of Viagra undeniably reshaped the drug landscape, but investing in companies heavily reliant on off-patent versions presents a complex picture. While early profits were significant, the cessation of patents and the rise of cheaper alternatives have eroded sales. Thus, a thorough assessment of current income sources and potential